Gardasil

Fierce Pharma

Merck unveils $3B cost-cutting plan

CEO Rob Davis called the restructuring a “multiyear optimization initiative” that will redirect resources from mature franchise to new growth drivers.

Kevin Dunleavy Jul 29, 2025 8:15am

From biotech CEO to 'expert patient': Michael Becker dies

Jul 10, 2019 10:57am